Hyoungil Kim - Publications

Affiliations: 
2017 Yonsei University, Seoul, South Korea 

285 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cho AR, Kim HJ, Lee HJ, Kim H, Do W, Kang C, Kim Y. Changes in the microvascular reactivity during spinal anesthesia. Microvascular Research. 104176. PMID 33984341 DOI: 10.1016/j.mvr.2021.104176  1
2021 Kim H, Park SH, Park JH, Lee KJ. Nonsurgical maxillary expansion in a 60-year-old patient with gingival recession and crowding. Korean Journal of Orthodontics. 51: 217-227. PMID 33984228 DOI: 10.4041/kjod.2021.51.3.217  1
2021 Yoo JH, Ok SY, Kim SH, Chung JW, Park SY, Kim MG, Cho HB, Song SH, Choi YJ, Kim HJ, Oh HC. Comparison of upper and lower body forced air blanket to prevent perioperative hypothermia in patients who underwent spinal surgery in prone position: A randomized controlled trial. Korean Journal of Anesthesiology. PMID 33984220 DOI: 10.4097/kja.21087  0.88
2021 Yoo JI, Sohn YJ, Son J, Jo SY, Pyo J, Park SK, Choi JI, Joo JC, Kim HT, Park SJ. Recent advances in the microbial production of C4 alcohols by metabolically engineered microorganisms. Biotechnology Journal. e2000451. PMID 33984183 DOI: 10.1002/biot.202000451  0.84
2021 Kim H, Hong JY, Jeon WJ, Lee J, Ha IH. Evaluation of the effects of differences in silicone hardness on rat model of lumbar spinal stenosis. Plos One. 16: e0251464. PMID 33984013 DOI: 10.1371/journal.pone.0251464  0.92
2021 Moon WK, Kim HS. Theranostics for Breast Cancer Stem Cells. Advances in Experimental Medicine and Biology. 1187: 267-281. PMID 33983583 DOI: 10.1007/978-981-32-9620-6_13  0.88
2021 Lee S, Kim EH, Yu S, Kim H, Park C, Lee SW, Han H, Jin W, Lee K, Lee CE, Jang J, Koo CM, Park C. Polymer-Laminated TiCT MXene Electrodes for Transparent and Flexible Field-Driven Electronics. Acs Nano. PMID 33983015 DOI: 10.1021/acsnano.1c01621  0.88
2021 Hormazabal-Peralta A, Lee KW, Lee HJ, Choi YJ, Hu KS, Kim HJ. Clinical Anatomy Considerations on the Muscular and Vascular Components of the Midface by Ultrasonographic Imaging. Clinical Anatomy (New York, N.Y.). PMID 33982323 DOI: 10.1002/ca.23754  1
2021 Kim H, Hong JY, Jeon WJ, Lee J, Baek SH, Ha IH. Turcz Exerts Neuroprotective Effects Against HO-Induced Neuroinflammation by Inhibiting NLRP3 Inflammasome Activation in Cortical Neurons. Journal of Inflammation Research. 14: 1759-1773. PMID 33981154 DOI: 10.2147/JIR.S305031  0.92
2021 Thangaraj JL, Ahn SY, Jung SH, Vo MC, Chu TH, Thi Phan MT, Kwon M, Lee KH, Kim M, Song GY, Yang DH, Ahn JS, Kim HJ, Cho D, Lee JJ. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cellular & Molecular Immunology. PMID 33980993 DOI: 10.1038/s41423-021-00686-9  1
2021 Kim MJ, Tagele SB, Jo H, Kim MC, Jung Y, Park YJ, So JH, Kim HJ, Kim HJ, Lee DG, Kang S, Shin JH. Effect of a bioconverted product of Lotus corniculatus seed on the axillary microbiome and body odor. Scientific Reports. 11: 10138. PMID 33980951 DOI: 10.1038/s41598-021-89606-5  0.92
2021 Choi H, Jung YI, Kim H. Implementation fidelity of the Systems for Person-Centered Elder Care (SPEC): a process evaluation study. Implementation Science : Is. 16: 52. PMID 33980251 DOI: 10.1186/s13012-021-01113-3  0.68
2021 Joo H, Moon JY, An TJ, Choi H, Park SY, Yoo H, Kim CY, Jeong I, Kim JH, Koo HK, Rhee CK, Lee SW, Kim SK, Min KH, Kim YH, ... ... Kim HJ, et al. Revised Korean Cough Guidelines, 2020: Recommendations and Summary statements. Tuberculosis and Respiratory Diseases. PMID 33979988 DOI: 10.4046/trd.2021.0038  0.88
2021 Kim HJ, Kim JE, Lee SH. Functional Impairment in Patients with Panic Disorder. Psychiatry Investigation. PMID 33979948 DOI: 10.30773/pi.2020.0425  1
2021 Pham CV, Lee SJ, Kim SY, Lee S, Kim SH, Kim HS. Age estimation based on 3D post-mortem computed tomography images of mandible and femur using convolutional neural networks. Plos One. 16: e0251388. PMID 33979376 DOI: 10.1371/journal.pone.0251388  0.96
2021 Kim HJ, Kim H, Kim YT, Sohn CH, Kim K, Kim DJ. Cerebrospinal fluid dynamics correlate with neurogenic claudication in lumbar spinal stenosis. Plos One. 16: e0250742. PMID 33979373 DOI: 10.1371/journal.pone.0250742  0.92
2021 Kim HK, Kim SS, Ki YJ, Park KH, Choi DH. Reply to the Letter to the Editor for the Article Entitled「Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim」. Acta Cardiologica Sinica. 37: 329. PMID 33978637 DOI: 10.6515/ACS.202105_37(3).20210323A  0.88
2021 Lim YK, Kweon OJ, Lee MK, Kim HR. Estimation of Measurement Uncertainty of Factor Assays Using the Monte Carlo Simulation. American Journal of Clinical Pathology. PMID 33978155 DOI: 10.1093/ajcp/aqab022  0.6
2021 Kim HJ, Shin SR, Oh HY, Kim JW, Lee JS. Sex of Mussel (Bivalvia: Mytilidae) : Sequential Hermaphroditism. Development & Reproduction. 25: 55-58. PMID 33977175 DOI: 10.12717/DR.2021.25.1.55  0.84
2021 Park S, Lee LE, Kim H, Kim JE, Lee SJ, Yoon S, Shin S, Kang H, Park Y, Song JJ, Lee S. Detection of intracellular monosodium urate crystals in gout synovial fluid using optical diffraction tomography. Scientific Reports. 11: 10019. PMID 33976275 DOI: 10.1038/s41598-021-89337-7  1
2021 Han EJ, Kim SY, Han HJ, Kim HS, Kim KN, Fernando IPS, Madusanka DMD, Dias MKHM, Cheong SH, Park SR, Han YS, Lee K, Ahn G. UVB protective effects of Sargassum horneri through the regulation of Nrf2 mediated antioxidant mechanism. Scientific Reports. 11: 9963. PMID 33976251 DOI: 10.1038/s41598-021-88949-3  0.84
2021 Kim SG, Lee S, Kim Y, Park J, Woo D, Kim D, Li Y, Shin W, Kang H, Yook C, Lee M, Kim K, Roh JD, Ryu J, Jung H, ... Kim H, et al. Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons. Nature Communications. 12: 2695. PMID 33976205 DOI: 10.1038/s41467-021-22908-4  0.96
2021 Lee JS, Cha YS, Yeon S, Kim TY, Lee Y, Choi JG, Cha KC, Lee KH, Kim H. Changes in Diagnosis of Poisoning in Patients in the Emergency Room Using Systematic Toxicological Analysis with the National Forensic Service. Journal of Korean Medical Science. 36: e118. PMID 33975395 DOI: 10.3346/jkms.2021.36.e118  0.96
2021 Jang Y, Kim HS, Lee JH, Ham SY, Park JH, Park HD. Development of a new method to evaluate critical flux and system reliability based on particle properties in a membrane bioreactor. Chemosphere. 280: 130763. PMID 33975240 DOI: 10.1016/j.chemosphere.2021.130763  1
2021 Choo OS, Kim H, Kim YJ, Roh J, Jang JH, Park HY, Choung YH. Effect of Age at Cochlear Implantation in Educational Placement and Peer Relationships. Ear and Hearing. PMID 33974787 DOI: 10.1097/AUD.0000000000001000  0.88
2021 Kim S, Lee J, Park M, Kim H, Kim S, Byun JW, Hwang-Bo J, Park KH. Technique for analyzing the transfer of colored cosmetics onto face masks. Skin Research and Technology : Official Journal of International Society For Bioengineering and the Skin (Isbs) [and] International Society For Digital Imaging of Skin (Isdis) [and] International Society For Skin Imaging (Issi). PMID 33974723 DOI: 10.1111/srt.13056  0.92
2021 Kim HO, Kim JC, Chung BY, Kang SY, Park CW, Han JH. Harlequin syndrome with petechiae caused by a pituitary adenoma. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 33974308 DOI: 10.1111/jdv.17338  0.8
2021 Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, et al. Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. Jama. 325: 1841-1851. PMID 33974018 DOI: 10.1001/jama.2021.4956  0.96
2021 Yoon JH, Kim H. CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine. Radiology. 210379. PMID 33973845 DOI: 10.1148/radiol.2021210379  0.68
2021 Nguyen VD, Min HK, Kim HY, Han J, Choi YH, Kim CS, Park JO, Choi E. Primary Macrophage-Based Microrobots: An Effective Tumor Therapy by Dual-Targeting Function and Near-Infrared-Triggered Drug Release. Acs Nano. PMID 33973786 DOI: 10.1021/acsnano.1c00114  0.56
2021 Lee SA, Kim SJ, Lee SY, Kim HJ. Clinical characteristics of periodic limb movements during sleep categorized by continuous positive airway pressure titration polysomnography in patients with obstructive sleep apnea. Sleep & Breathing = Schlaf & Atmung. PMID 33973111 DOI: 10.1007/s11325-021-02387-z  1
2021 Silwal P, Kim JK, Jeon SM, Lee JY, Kim YJ, Kim YS, Seo Y, Kim J, Kim SY, Lee MJ, Heo JY, Jung MJ, Kim HS, Hyun DW, Han JE, et al. Mitofusin-2 boosts innate immunity through the maintenance of aerobic glycolysis and activation of xenophagy in mice. Communications Biology. 4: 548. PMID 33972668 DOI: 10.1038/s42003-021-02073-6  1
2021 Park JE, Eun D, Kim HS, Lee DH, Jang RW, Kim N. Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type. Scientific Reports. 11: 9912. PMID 33972663 DOI: 10.1038/s41598-021-89477-w  0.72
2021 Basivi PK, Ramesh S, Kakani V, Yadav HM, Bathula C, Afsar N, Sivasamy A, Kim HS, Pasupuleti VR, Lee H. Ultrasonication-mediated nitrogen-doped multiwalled carbon nanotubes involving carboxy methylcellulose composite for solid-state supercapacitor applications. Scientific Reports. 11: 9918. PMID 33972653 DOI: 10.1038/s41598-021-89430-x  0.96
2021 Jeong YH, Hwang S, Lee GD, Choi SH, Kim HR, Kim YH, Park SI, Kim DK. Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Annals of Transplantation. 26: e930383. PMID 33972494 DOI: 10.12659/AOT.930383  0.8
2021 Kim J, Ryu S, Kim HY. Innate Lymphoid Cells in Tissue Homeostasis and Disease Pathogenesis. Molecules and Cells. PMID 33972473 DOI: 10.14348/molcells.2021.0053  0.88
2021 Kim HK, Jeong MG, Hwang ES. Post-Translational Modifications in Transcription Factors that Determine T Helper Cell Differentiation. Molecules and Cells. PMID 33972470 DOI: 10.14348/molcells.2021.0057  0.48
2021 Kim H, Jang S. RNA m6A methyltransferase Mettl3 regulates spatial neural patterning in . Molecular and Cellular Biology. PMID 33972392 DOI: 10.1128/MCB.00104-21  0.68
2021 Jeong SY, Cho YJ, Ryu JY, Choi JJ, Hwang JR, Kim B, Lee YY, Kim HS, Lee JW. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer. Gynecologic Oncology. PMID 33972086 DOI: 10.1016/j.ygyno.2021.04.028  1
2021 Nha KW, Kim HS, Cho ST, Bae JH, Jang KM, Kim SG. Arthroscopy-controlled medial reefing and lateral release for recurrent patellar dislocation: clinical, radiologic outcomes and complications. Bmc Musculoskeletal Disorders. 22: 430. PMID 33971864 DOI: 10.1186/s12891-021-04300-x  0.84
2021 Yoo SE, Lee JH, Lee JW, Park HS, Lee HA, Kim HS. Increasing prevalence of fasting hyperglycemia in adolescents aged 10-18 years and their relationship with metabolic indicators : The Korea National health and Nutrition Examination Study (KNHANES) 2007-2018. Annals of Pediatric Endocrinology & Metabolism. PMID 33971707 DOI: 10.6065/apem.2142068.034  1
2021 Jo SH, Kang SH, Seo WS, Koo BH, Kim HG, Yun SH. Psychiatric understanding and treatment of patients with amputations. Yeungnam University Journal of Medicine. PMID 33971697 DOI: 10.12701/yujm.2021.00990  0.72
2021 Lee HW, Kim HJ, Jang EJ, Lee CH. Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis. Respiration; International Review of Thoracic Diseases. 1-13. PMID 33971649 DOI: 10.1159/000515133  0.88
2021 Jung J, Park JY, Kim YC, Lee H, Kim E, Kim YS, Lee JP, Kim H. Effects of air pollution on mortality of patients with chronic kidney disease: A large observational cohort study. The Science of the Total Environment. 786: 147471. PMID 33971609 DOI: 10.1016/j.scitotenv.2021.147471  0.96
2021 Chen CY, Wang SW, Kim H, Pan SY, Fan C, Lin YJ. Non-conventional water reuse in agriculture: A circular water economy. Water Research. 199: 117193. PMID 33971532 DOI: 10.1016/j.watres.2021.117193  0.36
2021 Choi S, Ilyas S, Hwang G, Kim H. Sustainable treatment of bimetallic (Ag-Pd/α-AlO) catalyst waste from naptha cracking process: An innovative waste-to-value recycling of precious metals. Journal of Environmental Management. 291: 112748. PMID 33971514 DOI: 10.1016/j.jenvman.2021.112748  0.52
2021 Lee S, Jung JE, Kim HG, Lee Y, Park JM, Jang J, Yoon S, Ghosh A, Kim M, Kim J, Na W, Kim J, Choi HJ, Cheong H, Kim K. γ-GeSe: A New Hexagonal Polymorph from Group IV-VI Monochalcogenides. Nano Letters. PMID 33970636 DOI: 10.1021/acs.nanolett.1c00714  0.92
2021 Kim H, Choi B, Lee C, McAdam SAM, Paik JH, Jang TS. Micromorphological differentiation of Korean Disporum species using light and scanning electron microscopy. Microscopy Research and Technique. PMID 33969936 DOI: 10.1002/jemt.23812  0.8
2021 Lee MK, Zhang X, Kim HJ, Hwang YS. Peroxiredoxin 5 is involved in cancer cell invasion and tumor growth of oral squamous cell carcinoma. Oral Diseases. PMID 33969595 DOI: 10.1111/odi.13910  0.6
2021 Chang S, Fan Y, Lee SM, Ryu Y, Lee BH, Kim SC, Bills KB, Steffensen SC, Yang CH, Kim HY. Acupuncture reduces cocaine psychomotor responses by activating the rostromedial tegmental nucleus. Addiction Biology. e13052. PMID 33969586 DOI: 10.1111/adb.13052  0.76
2021 Hwang HK, Song KB, Park M, Kwon W, Jang JY, Heo JS, Choi DW, Kang CM, Park JS, Hong TH, Cho CK, Ahn KS, Lee H, Lee SE, Jeong CY, ... ... Kim HJ, et al. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method. Annals of Surgical Oncology. PMID 33969463 DOI: 10.1245/s10434-021-10092-0  0.96
2021 Yoon JG, Kim HB. Association between sunlight exposure and risk of prostate cancer: a systematic review and meta-analysis. European Journal of Public Health. PMID 33969413 DOI: 10.1093/eurpub/ckab059  0.8
2021 Kang M, Kim H. Unique characteristics that distinguish suicide attempters from patients with nonsuicidal self-injury admitted to the emergency department following self-harm behavior: Psychological scales and biochemical markers. Turkish Journal of Emergency Medicine. 21: 62-68. PMID 33969241 DOI: 10.4103/2452-2473.309134  1
2021 Jeon AY, Lee JH, Andriyono S, Zuweh JA, Kim HW. The complete mitochondrial genome of the blue runner, (Mitchill, 1815) (Teleostei: Carangidae). Mitochondrial Dna. Part B, Resources. 6: 1519-1520. PMID 33969210 DOI: 10.1080/23802359.2021.1917319  1
2021 Park SJ, Mun J, Lee EJ, Park S, Kim SY, Lim W, Song G, Kim JW, Lee S, Kim HS. Clinical Phenotypes of Tumors Invading the Rectosigmoid Colon Affecting the Extent of Debulking Surgery and Survival in Advanced Ovarian Cancer. Frontiers in Oncology. 11: 673631. PMID 33968784 DOI: 10.3389/fonc.2021.673631  0.96
2021 Lee JH, Hong HK, Kim WH, Kim HJ, Lee J, Park HY, Yang JD, Lee JS. Delayed unilateral hematoma after reconstructive and aesthetic breast surgery with implants in Asian patients: two case reports. Gland Surgery. 10: 1515-1522. PMID 33968703 DOI: 10.21037/gs-20-854  1
2021 Oh M, Seo M, Oh SY, Kim H, Choi BW, Oh JS, Kim JS. A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort. Nuclear Medicine and Molecular Imaging. 55: 71-78. PMID 33968273 DOI: 10.1007/s13139-021-00690-x  0.96
2021 Kim SH, Choo GS, Yoo ES, Woo JS, Lee JH, Han SH, Jung SH, Kim HJ, Jung JY. Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis. Oncology Letters. 21: 492. PMID 33968208 DOI: 10.3892/ol.2021.12753  1
2021 Kim ST, Park CI, Kim HW, Jeon S, Kang JI, Kim SJ. Dysfunctional Metacognitive Beliefs in Patients With Obsessive-Compulsive Disorder and Pattern of Their Changes Following a 3-Month Treatment. Frontiers in Psychiatry. 12: 628985. PMID 33967851 DOI: 10.3389/fpsyt.2021.628985  1
2021 Park MY, Yoon YS, Kim HE, Lee JL, Park IJ, Lim SB, Yu CS, Kim JC. Surgical options for perianal fistula in patients with Crohn's disease: A comparison of seton placement, fistulotomy, and stem cell therapy. Asian Journal of Surgery. PMID 33966965 DOI: 10.1016/j.asjsur.2021.03.013  0.8
2021 Park SM, Kim DA, Jo JK, Jun SK, Jang TS, Kim HW, Lee JH, Lee HH. Ceria-Incorporated Biopolymer for Preventing Fungal Adhesion. Acs Biomaterials Science & Engineering. 7: 1808-1816. PMID 33966380 DOI: 10.1021/acsbiomaterials.0c01039  1
2021 Chun JW, Kim J, Chung IIY, Ko BS, Kim HJ, Lee JW, Son BH, Ahn SH, Lee SB. Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. PMID 33966181 DOI: 10.1007/s10549-021-06249-w  1
2021 Kim HY, Kim YM, Hong S. DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1. Cell Death & Disease. 12: 461. PMID 33966034 DOI: 10.1038/s41419-021-03757-x  0.8
2021 Yang K, Park W, Cho J, Kang D, Choi DH, Kim H, Cho WK, Park H, Kim E. Chronological Skin Changes Through Postmastectomy Radiotherapy Based on Radiotherapy Techniques: Using Quantitative Dermatological Measurements. Skin Pharmacology and Physiology. 1-10. PMID 33965956 DOI: 10.1159/000515962  0.96
2021 Kim HS, Lee JH, Mandakhbayar N, Jin GZ, Kim SJ, Yoon JY, Jo SB, Park JH, Singh RK, Jang JH, Shin US, Knowles JC, Kim HW. Therapeutic tissue regenerative nanohybrids self-assembled from bioactive inorganic core / chitosan shell nanounits. Biomaterials. 274: 120857. PMID 33965799 DOI: 10.1016/j.biomaterials.2021.120857  1
2021 Chung KJ, Kim HN. Correction to: Use of a life-size three-dimensional-printed spine model for pedicle screw instrumentation training. Journal of Orthopaedic Surgery and Research. 16: 303. PMID 33964959 DOI: 10.1186/s13018-021-02429-y  0.4
2021 Shin DY, Hwang HS, Kim HS, Kim MS, Kim EC. Clinical differences between toric intraocular lens (IOL) and monofocal intraocular lens (IOL) implantation when myopia is determined as target refraction. Bmc Ophthalmology. 21: 203. PMID 33964915 DOI: 10.1186/s12886-021-01966-8  0.84
2021 Oh TH, Kim JW, Son SH, Kim H, Lee K, Lee JM. Automatic control of simulated moving bed process with deep Q-network. Journal of Chromatography. A. 1647: 462073. PMID 33964620 DOI: 10.1016/j.chroma.2021.462073  0.84
2021 Kang ES, Kim H, Han Y, Cho YW, Son H, Luo Z, Kim TH. Enhancing osteogenesis of adipose-derived mesenchymal stem cells using gold nanostructure/peptide-nanopatterned graphene oxide. Colloids and Surfaces. B, Biointerfaces. 204: 111807. PMID 33964530 DOI: 10.1016/j.colsurfb.2021.111807  0.52
2021 Lim JY, Oh SH, Park KN, Choi SP, Oh JS, Youn CS, Kim HJ, Kim HJ, Song H. Prognostic value of brainstem auditory and visual evoked potentials in cardiac arrest patients with targeted temperature management. Resuscitation. PMID 33964333 DOI: 10.1016/j.resuscitation.2021.04.024  0.76
2021 Ju MK, Shin KJ, Lee JR, Khim KW, A Lee E, Ra JS, Kim BG, Jo HS, Yoon JH, Kim TM, Myung K, Choi JH, Kim H, Chae YC. NSMF promotes the replication stress-induced DNA damage response for genome maintenance. Nucleic Acids Research. PMID 33963872 DOI: 10.1093/nar/gkab311  0.68
2021 Khan SA, Kim HM, Chun BH, Jeon CO. Devosia aurantiaca sp. nov., Isolated from Mountain Soil and Proposal of Albitalea gen. nov. to Replace the Illegitimate Prokaryotic Genus Name Geomonas Khan et al. 2020. Current Microbiology. PMID 33963447 DOI: 10.1007/s00284-021-02515-8  0.44
2021 Kim HJ, Hwang H, Hong H, Yim JJ, Lee J. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic. Scientific Reports. 11: 9784. PMID 33963250 DOI: 10.1038/s41598-021-89182-8  0.92
2021 Chandra Barman S, Sharifuzzaman M, Zahed MA, Park C, Yoon SH, Zhang S, Kim H, Yoon H, Park JY. A highly selective and stable cationic polyelectrolyte encapsulated black phosphorene based impedimetric immunosensor for Interleukin-6 biomarker detection. Biosensors & Bioelectronics. 186: 113287. PMID 33962178 DOI: 10.1016/j.bios.2021.113287  0.96
2021 Joo S, Kim K, Kwon O, Oh J, Kim HJ, Zhang L, Zhou J, Wang JQ, Jeong HY, Han JW, Kim G. Enhancing Thermocatalytic Activities via Up-shift of the d-Band Center of Exsolved Co-Ni-Fe Ternary Alloy Nanoparticles for Dry Reforming of Methane. Angewandte Chemie (International Ed. in English). PMID 33961725 DOI: 10.1002/anie.202101335  0.92
2021 Yoo KH, Kim HJ, Min YH, Hong DS, Lee WS, Kim HJ, Shin HJ, Park Y, Lee JH, Kim H. Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. Plos One. 16: e0251011. PMID 33961640 DOI: 10.1371/journal.pone.0251011  1
2021 Kwon HJ, Cha JY, Park JT, Kim HJ, Kim HJ. Reply: Effect of Cyclic Compressive Forces on New Bone Formation during the Distraction Period in Mandibular Distraction Osteogenesis Using a Microactuator-Generated Distractor. Plastic and Reconstructive Surgery. PMID 33961603 DOI: 10.1097/PRS.0000000000007948  0.84
2021 Acharya S, Adamová D, Adler A, Adolfsson J, Aggarwal MM, Aglieri Rinella G, Agnello M, Agrawal N, Ahammed Z, Ahmad S, Ahn SU, Akbar Z, Akindinov A, Al-Turany M, Alam SN, ... ... Kim H, et al. Elliptic Flow of Electrons from Beauty-Hadron Decays in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV. Physical Review Letters. 126: 162001. PMID 33961482 DOI: 10.1103/PhysRevLett.126.162001  0.96
2021 Muthike AK, Carlotti B, Madu IK, Jiang H, Kim H, Wu Q, Yu L, Zimmerman PM, Goodson T. The Role of the Core Attachment Positioning in Triggering Intramolecular Singlet Exciton Fission in Perylene Diimide Tetramers. The Journal of Physical Chemistry. B. PMID 33961426 DOI: 10.1021/acs.jpcb.1c02534  0.68
2021 Kim J, Yang KH, Choi AR, Kang MY, Kim HJ, Lee H, Lee JY. Healthcare Quality Assessments: No Guarantees of Same Outcomes for Different Socioeconomic Stroke Patients. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care. PMID 33961032 DOI: 10.1093/intqhc/mzab081  0.96
2021 Vo MC, Ahn SY, Chu TH, Uthaman S, Pillarisetti S, Uong TNT, Lakshmi TJ, Kim M, Song GY, Jung SH, Yang DH, Ahn JS, Kim HJ, Park IK, Lee JJ. A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy. Cellular & Molecular Immunology. PMID 33782574 DOI: 10.1038/s41423-021-00666-z  1
2021 Ahn SY, Park HK, Moon JH, Baek DW, Cho HJ, Sohn SK, Kang SR, Min JJ, Bom HS, Hong CM, Jeong SY, Song GY, Yang DH, Ahn JS, Kim HJ, et al. Prognostic impact of F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment. International Journal of Hematology. PMID 33475961 DOI: 10.1007/s12185-021-03079-w  1
2021 Song IC, Jo DY, Kim HJ, Min YH, Hong DS, Lee WS, Shin HJ, Lee JH, Park J, Kim HJ. Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data. Medicine. 100: e24185. PMID 33429807 DOI: 10.1097/MD.0000000000024185  1
2020 Ahn JS, Kim T, Jung SH, Ahn SY, Jung SY, Song GY, Kim M, Yang DH, Lee JJ, Choi S, Lee JY, Park SK, Moon JH, Lee HY, Kim KH, ... ... Kim HJ, et al. Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing. Bone Marrow Transplantation. PMID 33279940 DOI: 10.1038/s41409-020-01165-x  1
2020 Kim T, Moon JH, Ahn JS, Ahn SY, Jung SH, Yang DH, Lee JJ, Shin MG, Choi SH, Lee JY, Tyndel MS, Lee HY, Kim KH, Cai Y, Lee YJ, ... ... Kim HJ, et al. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia. Scientific Reports. 10: 20119. PMID 33208771 DOI: 10.1038/s41598-020-76933-2  1
2020 Ahn SY, Kim HK, Kang HC, Kim M, Song GY, Jung SH, Ahn JS, Yang DH, Kim HJ, Lee JJ. Adrenal insufficiency in hospitalized patients with multiple myeloma. Leukemia & Lymphoma. 1-3. PMID 33135942 DOI: 10.1080/10428194.2020.1834095  1
2020 Song GY, Jung SH, Kim K, Kim SJ, Yoon SE, Lee HS, Kim M, Ahn SY, Ahn JS, Yang DH, Kim HJ, Lee JJ. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma. Bmc Cancer. 20: 803. PMID 32831058 DOI: 10.1186/s12885-020-07317-y  1
2020 Jung SH, Jo JC, Song GY, Ahn SY, Yang DH, Ahn JS, Kim HJ, Lee JJ. Frontline therapy for newly diagnosed patients with multiple myeloma. Blood Research. 55: S37-S42. PMID 32719175 DOI: 10.5045/br.2020.S007  1
2020 Chu TH, Vo MC, Park HS, Lakshmi TJ, Jung SH, Kim HJ, Lee JJ. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma. Cancer Immunology, Immunotherapy : Cii. PMID 32623477 DOI: 10.1007/s00262-020-02654-0  1
2020 Baek DW, Cho HJ, Kim JH, Sohn SK, Song GY, Ahn SY, Jung SH, Ahn JS, Lee JJ, Kim HJ, Jeong SY, Hong CM, Min JJ, Moon JH, Yang DH. Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma. In Vivo (Athens, Greece). 34: 2127-2134. PMID 32606193 DOI: 10.21873/invivo.12018  1
2020 Do YR, Kwak JY, Kim JA, Kim HJ, Chung JS, Shin HJ, Kim SH, Bunworasate U, Choi CW, Zang DY, Oh SJ, Jootar S, Reksodiputro AH, Lee WS, Mun YC, ... ... Kim H, et al. Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE). British Journal of Haematology. PMID 32012231 DOI: 10.1111/bjh.16381  0.96
2019 Ahn SY, Jung SY, Jung SH, Ahn JS, Lee JJ, Kim HJ, Kang SR, Han YH, Kwak JY, Yhim HY, Yang DH. Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas. Annals of Hematology. PMID 31807859 DOI: 10.1007/s00277-019-03867-9  1
2019 Ahn JS, Kim T, Kim YK, Cho YC, Cho S, Jung SH, Ahn SY, Jung SY, Yang DH, Lee JJ, Choi S, Lee JY, Shin MG, Yoshida K, Ogawa S, ... ... Kim HJ, et al. Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone. Experimental Hematology. PMID 31199945 DOI: 10.1016/J.Exphem.2019.06.001  1
2019 Park S, Baek DW, Sohn SK, Ahn JS, Kim HJ, Shin HJ, Chung JS, Lee SM, Lee WS, Lim SN, Lee YJ, Choi Y, Lee HS, Cho YY, Lee GW, et al. Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome. Clinical Lymphoma, Myeloma & Leukemia. PMID 31060990 DOI: 10.1016/j.clml.2019.03.016  0.96
2019 Shin HJ, Min WS, Min YH, Cheong JW, Lee JH, Kim IH, Hong DS, Ahn JS, Kim HJ, Lee WS, Jung CW, Jang JH, Park Y, Kim HJ. Different prognostic effects of core-binding factor positive AML with Korean AML registry data. Annals of Hematology. PMID 30758645 DOI: 10.1007/s00277-019-03624-y  1
2019 Vo MC, Lakshmi TJ, Jung SH, Cho D, Park HS, Chu TH, Lee HJ, Kim HJ, Kim SK, Lee JJ. Cellular immunotherapy in multiple myeloma. The Korean Journal of Internal Medicine. PMID 30754964 DOI: 10.3904/kjim.2018.325  1
2019 Song GY, Jung SH, Ahn SY, Jung SY, Yang DH, Ahn JS, Kim HJ, Lee JJ. Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma. Bmc Cancer. 19: 59. PMID 30642286 DOI: 10.1186/s12885-019-5285-1  1
2018 Park JH, Woo YM, Youm EM, Hamad N, Won HH, Naka K, Park EJ, Park JH, Kim HJ, Kim SH, Kim HJ, Ahn JS, Sohn SK, Moon JH, Jung CW, et al. HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia. Leukemia. PMID 30555164 DOI: 10.1038/s41375-018-0321-8  1
2018 Lee YJ, Baek DW, Ahn JS, Ahn SY, Jung SH, Yang DH, Lee JJ, Kim HJ, Ham JY, Suh JS, Sohn SK, Moon JH. Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission. Clinical Lymphoma, Myeloma & Leukemia. PMID 30268640 DOI: 10.1016/j.clml.2018.08.010  1
2018 Jung SH, Kwon SY, Min JJ, Bom HS, Ahn SY, Jung SY, Lee SS, Park MR, Yang DH, Ahn JS, Kim HJ, Lee JJ. F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30187105 DOI: 10.1007/s00259-018-4114-0  1
2018 Vo MC, Yang S, Jung SH, Chu TH, Lee HJ, Lakshmi TJ, Park HS, Kim HJ, Lee JJ. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model. Frontiers in Immunology. 9: 1798. PMID 30123221 DOI: 10.3389/fimmu.2018.01798  1
2018 Kim T, Moon JH, Ahn JS, Kim YK, Lee SS, Ahn SY, Jung SH, Yang DH, Lee JJ, Choi SH, Lee JY, Tyndel MS, Shin MG, Lee YJ, Sohn SK, ... ... Kim HJ, et al. Next-generation sequencing based post-transplant monitoring of acute myeloid leukemia. Blood. PMID 30108064 DOI: 10.1182/Blood-2018-04-848028  1
2018 Kim H, Kim S, Kim HJ, Kim YK, Kwak JY, Yhim HY, Kim SH, Do YR, Oh S, Lee SE, Jootar S, Cui JW, Kim DW. Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia. Clinical Lymphoma, Myeloma & Leukemia. PMID 30082224 DOI: 10.1016/j.clml.2018.06.031  0.96
2018 Baek DW, Lee YJ, Kim H, Ahn SY, Ahn JS, Shin HJ, Lee WS, Lee SM, Song IC, Lee HS, Park SW, Choi Y, Cho YY, Bae SH, Kim HJ, et al. Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts. Annals of Hematology. PMID 30073392 DOI: 10.1007/s00277-018-3458-7  0.96
2018 Kim T, Choi HY, Lee HS, Jung SH, Ahn JS, Kim HJ, Lee JJ, Yoo HD, Yang DH. Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL). Bmc Cancer. 18: 729. PMID 29986691 DOI: 10.1186/s12885-018-4632-y  1
2018 Vo MC, Jung SH, Chu TH, Lee HJ, Lakshmi TJ, Park HS, Kim HJ, Rhee JH, Lee JJ. Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma. Frontiers in Immunology. 9: 1370. PMID 29967612 DOI: 10.3389/fimmu.2018.01370  1
2018 Lee SE, Choi SY, Kim SH, Jootar S, Kim HJ, Sohn SK, Park JS, Kim SH, Zang DY, Oh SJ, Kim DW. Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib. Leukemia Research. 70: 100-105. PMID 29908417 DOI: 10.1016/j.leukres.2018.06.002  0.96
2018 Ahn SY, Kwon SY, Jung SH, Ahn JS, Yoo SW, Min JJ, Bom HS, Ki SY, Kim HJ, Lee JJ, Song SY, Yang DH. Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. PMID 29877882 DOI: 10.1097/RLU.0000000000002154  1
2018 Park S, Choi H, Kim HJ, Ahn JS, Kim HJ, Kim SH, Mun YC, Jung CW, Kim DDH. Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients. Annals of Hematology. PMID 29500710 DOI: 10.1007/s00277-018-3260-6  0.96
2018 Ahn JS, Kim HJ, Kim YK, Lee SS, Ahn SY, Jung SH, Yang DH, Lee JJ, Park HJ, Lee JY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, et al. Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype. Oncotarget. 9: 4961-4968. PMID 29435155 DOI: 10.18632/Oncotarget.23575  1
2017 Jung SH, Ahn SY, Choi HW, Shin MG, Lee SS, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma. Blood Research. 52: 293-299. PMID 29333406 DOI: 10.5045/br.2017.52.4.293  1
2017 Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, et al. Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28939746 DOI: 10.1158/1078-0432.CCR-17-0957  0.96
2017 Lee JH, Kim YJ, Sohn SK, Yoon SS, Kim H, Cheong JW, Lee WS, Lee GW, Lim SN, Kim MK, Lee HS, Kim HJ. Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study. Leukemia Research. 60: 135-144. PMID 28826063 DOI: 10.1016/j.leukres.2017.08.004  1
2017 Kim T, Tyndel MS, Zhang Z, Ahn J, Choi S, Szardenings M, Lipton JH, Kim HJ, Kim Dong Hwan D. Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy. Leukemia Research. 59: 142-148. PMID 28667884 DOI: 10.1016/J.Leukres.2017.06.009  0.88
2017 Kim DJ, Lee HS, Moon JH, Sohn SK, Kim HJ, Cheong JW, Jo DY, Kim H, Lee H, Bang SM, Lee WS, Park Y, Lee MH, Lee JH, Bae SH, et al. Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS working party. Oncotarget. PMID 28624804 DOI: 10.18632/oncotarget.18258  1
2017 Vo MC, Nguyen-Pham TN, Lee HJ, Jung SH, Choi NR, Hoang MD, Kim HJ, Lee JJ. Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells. Oncotarget. PMID 28512265 DOI: 10.18632/oncotarget.17517  1
2017 Jung SH, Kim K, Kim JS, Kim SJ, Cheong JW, Kim SJ, Ahn JS, Ahn SY, Yang DH, Kim HJ, Lee JJ. A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System. British Journal of Haematology. PMID 28466549 DOI: 10.1111/bjh.14701  1
2017 Vo MC, Nguyen-Pham TN, Lee HJ, Jaya Lakshmi T, Yang S, Jung SH, Kim HJ, Lee JJ. Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model. Oncotarget. 8: 27252-27262. PMID 28460478 DOI: 10.18632/oncotarget.15917  1
2017 Jung SH, Lee HJ, Vo MC, Kim HJ, Lee JJ. Immunotherapy for the treatment of multiple myeloma. Critical Reviews in Oncology/Hematology. 111: 87-93. PMID 28259300 DOI: 10.1016/j.critrevonc.2017.01.011  1
2017 Jung SH, Lee HJ, Lee YK, Yang DH, Kim HJ, Rhee JH, Emmrich F, Lee JJ. A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma. Oncotarget. PMID 28088784 DOI: 10.18632/oncotarget.14582  1
2016 Ahn JS, Kim HJ, Kim YK, Lee SS, Ahn SY, Jung SH, Yang DH, Lee JJ, Park HJ, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, et al. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. Oncotarget. PMID 28039446 DOI: 10.18632/oncotarget.14171  1
2016 Vo MC, Anh-NguyenThi T, Lee HJ, Nguyen-Pham TN, Jaya Lakshmi T, Jung SH, Kim HJ, Lee JJ. Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma. Experimental Hematology. PMID 27889516 DOI: 10.1016/j.exphem.2016.11.004  1
2016 Suh KJ, Cheong JW, Kim I, Kim HJ, Shin DY, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, et al. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome. Plos One. 11: e0166245. PMID 27824923 DOI: 10.1371/journal.pone.0166245  1
2016 Kim T, Tyndel MS, Kim HJ, Ahn JS, Choi SH, Park HJ, Kim YK, Kim SY, Lipton JH, Zhang Z, Kim DD. Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy. Blood. PMID 27733357 DOI: 10.1182/Blood-2016-04-708560  0.96
2016 Hong CY, Lee HJ, Choi NR, Jung SH, Vo MC, Hoang MD, Kim HJ, Lee JJ. Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells. Experimental & Molecular Medicine. 48: e253. PMID 27538371 DOI: 10.1038/emm.2016.69  0.84
2016 Jung SH, Cho MS, Kim HK, Kim SJ, Kim K, Cheong JW, Kim SJ, Kim JS, Ahn JS, Kim YK, Yang DH, Kim HJ, Lee JJ. Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen. Bmc Cancer. 16: 613. PMID 27501959 DOI: 10.1186/s12885-016-2645-y  0.76
2016 Lee SS, Jung SH, Ahn JS, Kim YK, Cho MS, Jung SY, Lee JJ, Kim HJ, Yang DH. Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients. Journal of Korean Medical Science. 31: 1160-3. PMID 27366017 DOI: 10.3346/jkms.2016.31.7.1160  1
2016 Jung SH, Choi HJ, Shin MG, Lee SS, Hwang EC, Jung TY, Cho MS, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression. Annals of Hematology. PMID 27365142 DOI: 10.1007/s00277-016-2743-6  0.92
2016 Jun CH, Kim BS, Oak CY, Lee DH, Cho E, Cho SB, Choi SK, Park CH, Joo YE, Lee JJ, Kim HJ. HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea. Hepatology International. PMID 27351765 DOI: 10.1007/s12072-016-9747-0  0.92
2016 Nguyen HH, Kim T, Song SY, Park S, Cho HH, Jung SH, Ahn JS, Kim HJ, Lee JJ, Kim HO, Cho JH, Yang DH. Naïve CD8(+) T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment. Scientific Reports. 6: 28208. PMID 27306834 DOI: 10.1038/srep28208  1
2016 Byun JM, Kim YJ, Yoon HJ, Kim SY, Kim HJ, Yoon J, Min YH, Cheong JW, Park J, Lee JH, Hong DS, Park SK, Kim HJ, Ahn JS, Shin HJ, et al. Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study. Annals of Hematology. PMID 27230620 DOI: 10.1007/s00277-016-2691-1  0.84
2016 Zheng Q, Cao J, Hamad N, Kim HJ, Moon JH, Sohn SK, Jung CW, Lipton JH, Kim DD. Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia. Journal of Translational Medicine. 14: 82. PMID 27009330 DOI: 10.1186/s12967-016-0837-5  0.92
2016 Lee SE, Choi SY, Song HY, Kim SH, Choi MY, Park JS, Kim HJ, Kim SH, Zang DY, Oh S, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, et al. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study. Haematologica. PMID 26888022 DOI: 10.3324/haematol.2015.139899  0.8
2015 Yang DH, Jung SH, Ahn JS, Kim YK, Min JJ, Bom HS, Lee JJ, Kim HJ. Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma. Chonnam Medical Journal. 51: 109-14. PMID 26730361 DOI: 10.4068/cmj.2015.51.3.109  1
2015 Ahn JS, Kim HJ, Kim YK, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, et al. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML. Annals of Hematology. PMID 26692090 DOI: 10.1007/s00277-015-2580-z  0.92
2015 Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, et al. Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant. Annals of Hematology. PMID 26630982 DOI: 10.1007/s00277-015-2563-0  1
2015 Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, et al. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant. Annals of Hematology. PMID 26537612 DOI: 10.1007/s00277-015-2540-7  0.96
2015 Jung SH, Kim JS, Lee WS, Oh SJ, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen. Annals of Hematology. PMID 26467916 DOI: 10.1007/s00277-015-2521-x  0.96
2015 Jung SH, Ahn JS, Yang DH, Cho MS, Kim JY, Ahn SY, Kim YK, Kim HJ, Lee JJ. Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment. Blood Research. 50: 167-72. PMID 26457284 DOI: 10.5045/br.2015.50.3.167  1
2015 Nguyen-Pham TN, Jung SH, Vo MC, Thanh-Tran HT, Lee YK, Lee HJ, Choi NR, Hoang MD, Kim HJ, Lee JJ. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 330-339. PMID 26325377 DOI: 10.1097/CJI.0000000000000097  1
2015 Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K. A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes. International Journal of Hematology. PMID 26323997 DOI: 10.1007/s12185-015-1862-5  0.96
2015 Ahn JS, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, et al. DNMT3A R882 mutation with FLT3-ITD positivity is an extremely poor prognostic factor in patients with normal-karyotype AML after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26234722 DOI: 10.1016/j.bbmt.2015.07.030  0.96
2015 Lim SN, Joo YD, Lee KH, Kim DY, Lee JH, Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo HM, ... ... Kim HJ, ... ... Kim H, et al. Long-term follow-up of imatinib plus combination chemotherapy in for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. American Journal of Hematology. PMID 26228525 DOI: 10.1002/ajh.24137  0.88
2015 Hoang MD, Lee HJ, Lee HJ, Jung SH, Choi NR, Vo MC, Nguyen-Pham TN, Kim HJ, Park IK, Lee JJ. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells. Journal of Immunology Research. 2015: 706379. PMID 26221615 DOI: 10.1155/2015/706379  0.96
2015 Choi NR, Lee HJ, Jung SH, Hong CY, Vo MC, Hoang MD, Kim HJ, Lee JJ. Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco/endoplasmic reticulum Ca(2+) transport ATPase 2 regulation. Cytotherapy. 17: 1421-33. PMID 26212610 DOI: 10.1016/j.jcyt.2015.06.002  1
2015 Ahn JS, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, ... ... Kim HJ, et al. Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome. Acta Haematologica. 134: 40-8. PMID 26066466 DOI: 10.1159/000368711  0.88
2015 Song JH, Cho KM, Kim HJ, Kim YK, Kim NY, Kim HJ, Lee TH, Hwang SY, Kim TS. Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy. Oncology Reports. 34: 488-94. PMID 25955569 DOI: 10.3892/or.2015.3959  0.96
2015 Park JS, Lee SE, Jeong SH, Jang EJ, Choi MY, Kim HJ, Kim YK, Kim SH, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak JY, Kim JA, et al. Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients. Leukemia & Lymphoma. 1-7. PMID 25947037 DOI: 10.3109/10428194.2015.1049166  0.8
2015 Park SH, Lee HJ, Kim IS, Kang JE, Lee EY, Kim HJ, Kim YK, Won JH, Bang SM, Kim H, Song MK, Chung JS, Shin HJ. Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population. Annals of Laboratory Medicine. 35: 288-97. PMID 25932436 DOI: 10.3343/alm.2015.35.3.288  0.88
2015 Hoang MD, Jung SH, Lee HJ, Lee YK, Nguyen-Pham TN, Choi NR, Vo MC, Lee SS, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic. Chonnam Medical Journal. 51: 1-7. PMID 25914874 DOI: 10.4068/cmj.2015.51.1.1  1
2015 Jung SH, Ahn JS, Kim YK, Kweon SS, Min JJ, Bom HS, Kim HJ, Chae YS, Moon JH, Sohn SK, Lee SW, Byun BH, Do YR, Lee JJ, Yang DH. Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma. Bmc Cancer. 15: 198. PMID 25879747 DOI: 10.1186/s12885-015-1193-1  0.96
2015 Sung HJ, Lee SR, Choi IK, Park Y, Choi CW, Kim HJ, Yhim HY, Kim BS. Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage. Acta Haematologica. 134: 59-68. PMID 25871321 DOI: 10.1159/000369444  0.96
2015 Kim YK, Lee SS, Jeong SH, Ahn JS, Yang DH, Lee JJ, Kim HJ. Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia. Blood Research. 50: 19-25. PMID 25830126 DOI: 10.5045/br.2015.50.1.19  1
2015 Song JH, Lee JE, Cho KM, Park SH, Kim HJ, Kim YC, Kim TS. 5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities. Molecular Carcinogenesis. PMID 25788004 DOI: 10.1002/mc.22307  0.96
2015 Lee SS, Ahn JS, Jung SH, Ahn SY, Kim JY, Jang HC, Kang SJ, Jang MO, Yang DH, Kim YK, Lee JJ, Kim HJ. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation. The Korean Journal of Internal Medicine. 30: 212-8. PMID 25750563 DOI: 10.3904/kjim.2015.30.2.212  1
2015 Bassig BA, Cerhan JR, Au WY, Kim HN, Sangrajrang S, Hu W, Tse J, Berndt S, Zheng T, Zhang H, Pornsopone P, Lee JJ, Kim HJ, Skibola CF, Vijai J, et al. Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations. European Journal of Haematology. PMID 25611436 DOI: 10.1111/Ejh.12513  1
2015 Jung SH, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma. Acta Haematologica. 133: 10-7. PMID 24969101 DOI: 10.1159/000360068  1
2015 Kwak J, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Chung JS, Shin H, Kim S, Kim D, Bunworasate U, Choi CW, Comia NSC, Zang DY, Oh S, et al. Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial Blood. 126: 476-476. DOI: 10.1182/blood.V126.23.476.476  0.96
2015 Lee S, Choi SY, Kwak J, Kim H, Kim J, Do YR, Kim HJ, Park JS, Chung JS, Shin H, Kim S, Kim D, Bunworasate U, Choi CW, Comia NSC, et al. Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib Blood. 126: 4053-4053. DOI: 10.1182/blood.V126.23.4053.4053  0.96
2015 Rothman N, Bassig BA, Cerhan JR, Au W, Kim HN, Sangrajrang S, Hu W, Tse J, Berndt S, Zheng T, Zhang H, Pornsopone P, Lee J, Kim H, Skibola CF, et al. Abstract 4626: Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations Cancer Research. 75: 4626-4626. DOI: 10.1158/1538-7445.Am2015-4626  0.92
2014 Kim YK, Lee SS, Jeong SH, Ahn JS, Yang DH, Lee JJ, Shin MG, Kim HJ. OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib. Chonnam Medical Journal. 50: 102-11. PMID 25568846 DOI: 10.4068/cmj.2014.50.3.102  1
2014 Ahn JS, Jung SH, Lee SS, Ahn SY, Yang DH, Kim YK, Kim HJ, Lee JJ. Clinical outcome of bortezomib retreatment in patients with relapsed or refractory multiple myeloma. Biomed Research International. 2014: 145843. PMID 25530955 DOI: 10.1155/2014/145843  1
2014 Jung SH, Kang SJ, Jang HC, Ahn JS, Yang DH, Lee SS, Kim YK, Kim HJ, Lee JJ. Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens. International Journal of Hematology. 100: 473-7. PMID 25212681 DOI: 10.1007/s12185-014-1672-1  1
2014 Choi DB, Park MR, Kim HR, Jun CD, Kim HJ, Shim H, Kim YD, Choi C, Choi KH, Yun KJ, Chae SC, Park R, Choe SK, Lee YJ, Park DS. Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia. Leukemia Research. 38: 1252-9. PMID 25176346 DOI: 10.1016/j.leukres.2014.08.001  0.8
2014 Nguyen KC, Muthiah M, Islam MA, Kalash RS, Cho CS, Park H, Lee IK, Kim HJ, Park IK, Cho KA. Selective transfection with osmotically active sorbitol modified PEI nanoparticles for enhanced anti-cancer gene therapy. Colloids and Surfaces. B, Biointerfaces. 119: 126-36. PMID 24880989 DOI: 10.1016/j.colsurfb.2014.05.003  0.96
2014 Jung SH, Jang HC, Lee SS, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. The impact of hyperglycemia on risk of severe infections during early period of induction therapy in patients with newly diagnosed multiple myeloma. Biomed Research International. 2014: 413149. PMID 24822205 DOI: 10.1155/2014/413149  1
2014 Kim HN, Kim NY, Yu L, Kim YK, Lee IK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Kim HJ. Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma. International Journal of Molecular Sciences. 15: 6703-16. PMID 24756092 DOI: 10.3390/ijms15046703  1
2014 Kim SH, Menon H, Jootar S, Saikia T, Kwak JY, Sohn SK, Park JS, Jeong SH, Kim HJ, Kim YK, Oh SJ, Kim H, Zang DY, Chung JS, Shin HJ, et al. Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. Haematologica. 99: 1191-6. PMID 24705186 DOI: 10.3324/haematol.2013.096776  0.88
2014 Ahn JS, Jung SH, Yang DH, Bae SY, Kim YK, Kim HJ, Lee JJ. Patterns of relapse or progression after bortezomib-based salvage therapy in patients with relapsed/refractory multiple myeloma. Clinical Lymphoma, Myeloma & Leukemia. 14: 389-94. PMID 24630919 DOI: 10.1016/j.clml.2014.02.004  1
2014 Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, McLeod JL, Doedens M, Medeiros JJ, Marke R, Kim HJ, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 506: 328-33. PMID 24522528 DOI: 10.1038/nature13038  0.96
2014 Jung SH, Lee YK, Lee HJ, Choi NR, Vo MC, Hoang MD, Lim MS, Nguyen-Pham TN, Kim HJ, Lee JJ. Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro. Experimental Hematology. 42: 274-81. PMID 24407159 DOI: 10.1016/j.exphem.2013.12.008  1
2014 Song JH, Kim SH, Cho KM, Hwang SY, Kim HJ, Kim TS. Analysis of gene profiles involved in the enhancement of all-trans retinoic acid-induced HL-60 cell differentiation by sesquiterpene lactones identifies asparagine synthetase as a novel target for differentiation-inducing therapy. International Journal of Oncology. 44: 970-6. PMID 24398846 DOI: 10.3892/ijo.2013.2241  0.92
2014 Cheong JW, Kim HJ, Lee KH, Yoon SS, Lee JH, Park HS, Kim HY, Shim H, Seong CM, Kim CS, Chung J, Hyun MS, Jo DY, Jung CW, Sohn SK, et al. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia. Transfusion. 54: 1542-51. PMID 24313463 DOI: 10.1111/trf.12507  0.8
2014 Lim S, Lee K, Kim D, Lee J, Lee J, Chi H, Joo Y, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo H, Bae SH, ... ... Kim H, ... ... Kim HY, ... ... Kim HJ, et al. Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Blood. 124: 3654-3654. DOI: 10.1182/blood.v124.21.3654.3654  0.96
2013 Jang JH, Lee JH, Yoon SS, Jo DY, Kim HJ, Chung J, Lee JW. Korean guideline for iron chelation therapy in transfusion-induced iron overload. Journal of Korean Medical Science. 28: 1563-72. PMID 24265517 DOI: 10.3346/jkms.2013.28.11.1563  1
2013 Choi H, Jung C, Sohn SK, Kim S, Kim HJ, Kim YK, Kim T, Zhang Z, Shin ES, Lee JE, Moon JH, Kim SH, Kim KH, Mun YC, Kim H, et al. Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype. British Journal of Haematology. 163: 62-71. PMID 24159609 DOI: 10.1182/Blood.V120.21.2526.2526  0.88
2013 Kang BW, Moon JH, Chae YS, Lee SJ, Kim JG, Kim YK, Lee JJ, Yang DH, Kim HJ, Kim JY, Do YR, Park KU, Song HS, Kwon KY, Kim MK, ... ... Kim H, et al. Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 45: 112-7. PMID 23864844 DOI: 10.4143/crt.2013.45.2.112  0.8
2013 Kim YJ, Jang JH, Kwak JY, Lee JH, Kim HJ. Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations. Blood Research. 48: 87-98. PMID 23826577 DOI: 10.5045/br.2013.48.2.87  1
2013 Ahn JS, Yang DH, Duk Choi Y, Jung SH, Yhim HY, Kwak JY, Sung Park H, Shin MG, Kim YK, Kim HJ, Lee JJ. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. American Journal of Hematology. 88: 774-9. PMID 23760676 DOI: 10.1002/ajh.23507  1
2013 Hosgood HD, Au WY, Kim HN, Liu J, Hu W, Tse J, Song B, Wong KF, Lee JJ, Chanock SJ, Siu LP, Purdue MP, Shin MH, Yu J, Liang R, ... Kim HJ, et al. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. International Journal of Hematology. 97: 793-9. PMID 23640160 DOI: 10.1007/S12185-013-1345-5  1
2013 Won EJ, Kim HR, Kim HY, Kook H, Kim HJ, Shin JH, Suh SP, Ryang DW, Shin MG. Diagnostic and prognostic value of mitochondrial DNA minisatellites after stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 918-24. PMID 23499734 DOI: 10.1016/j.bbmt.2013.03.002  0.72
2013 Lee SE, Choi SY, Bang JH, Kim SH, Jang EJ, Byeun JY, Park JE, Jeon HR, Oh YJ, Kim HJ, Kim YK, Park JS, Jeong SH, Kim SH, Zang DY, ... ... Kim H, et al. Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib. American Journal of Hematology. 88: 449-54. PMID 23440689 DOI: 10.1002/ajh.23427  0.88
2013 Lee YG, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Park J, ... ... Kim HJ, et al. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes. British Journal of Haematology. 161: 339-47. PMID 23432512 DOI: 10.1111/bjh.12256  0.96
2013 Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial. Annals of Hematology. 92: 789-97. PMID 23358616 DOI: 10.1007/s00277-013-1685-5  0.96
2013 Jung SH, Bae SY, Ahn JS, Kang SJ, Yang DH, Kim YK, Kim HJ, Lee JJ. Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens. International Journal of Hematology. 97: 382-7. PMID 23355264 DOI: 10.1007/s12185-013-1270-7  1
2013 Kim HR, Choi HJ, Kim YK, Kim HJ, Shin JH, Suh SP, Ryang DW, Shin MG. Allelic expression imbalance of JAK2 V617F mutation in BCR-ABL negative myeloproliferative neoplasms. Plos One. 8: e52518. PMID 23349688 DOI: 10.1371/journal.pone.0052518  0.88
2013 Yi JH, Huh J, Kim HJ, Kim SH, Kim SH, Kim KH, Do YR, Mun YC, Kim H, Kim MK, Kim HJ, Kim T, Kim DD. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment. Annals of Hematology. 92: 459-69. PMID 23262795 DOI: 10.1007/s00277-012-1635-7  0.88
2013 Yang DH, Ahn JS, Byun BH, Min JJ, Kweon SS, Chae YS, Sohn SK, Lee SW, Kim HW, Jung SH, Kim YK, Kim HJ, Bom HS, Lee JJ. Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era. Annals of Hematology. 92: 471-9. PMID 23238895 DOI: 10.1007/s00277-012-1640-x  0.92
2013 Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, ... ... Kim HJ, et al. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Annals of Hematology. 92: 163-71. PMID 23053179 DOI: 10.1007/s00277-012-1580-5  0.88
2012 Huh J, Kim HJ, Jung CW, Kim HJ, Kim SH, Kim YK, Kim HJ, Shin MG, Moon JH, Sohn SK, Kim SH, Lee WS, Won JH, Mun YC, Kim H, et al. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia. American Journal of Hematology. 87: 961-8. PMID 22886749 DOI: 10.1002/ajh.23281  0.88
2012 Kong JH, Mun YC, Kim S, Choi HS, Kim YK, Kim HJ, Moon JH, Sohn SK, Kim SH, Jung CW, Dennis Kim DH. Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia. International Journal of Hematology. 96: 327-33. PMID 22821389 DOI: 10.1007/s12185-012-1142-6  0.96
2012 Jung SH, Ahn JS, Yang DH, Chul Park H, Bae SY, Kim YK, Kim HJ, Lee JJ. Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation. Case Reports in Oncology. 5: 110-3. PMID 22539923 DOI: 10.1159/000337022  1
2012 Ahn JS, Yang DH, Jung SH, Park HC, Moon JH, Sohn SK, Bae SY, Kim YK, Kim HJ, Lee JJ. A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma. Annals of Hematology. 91: 1023-30. PMID 22314843 DOI: 10.1007/s00277-012-1420-7  1
2012 Lee HJ, Hong CY, Jin CJ, Kim MH, Lee YK, Nguyen-Pham TN, Lee H, Park BC, Chung IJ, Kim HJ, Lee JJ. Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer. Cellular & Molecular Immunology. 9: 175-83. PMID 22231555 DOI: 10.1038/cmi.2011.52  1
2012 Lee SJ, Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Le SM, Joo YD, et al. Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia. Acta Haematologica. 127: 81-9. PMID 22143083 DOI: 10.1159/000333133  0.96
2012 Lee HJ, Hong CY, Kim MH, Lee YK, Nguyen-Pham TN, Park BC, Yang DH, Chung IJ, Kim HJ, Lee JJ. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer. Experimental & Molecular Medicine. 44: 60-7. PMID 22089087 DOI: 10.3858/emm.2012.44.1.006  0.96
2012 Kim HN, Kim NY, Yu L, Tran HT, Kim YK, Lee IK, Shin MH, Park KS, Choi JS, Kim HJ. Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status. Leukemia & Lymphoma. 53: 681-7. PMID 21942242 DOI: 10.3109/10428194.2011.625576  0.96
2012 Nguyen-Pham TN, Yang DH, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Lee JJ. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy. Cellular & Molecular Immunology. 9: 45-53. PMID 21822297 DOI: 10.1038/cmi.2011.23  1
2012 Oh SY, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Kang HJ, Song MK, Kim HJ, Kwon JH, Kwak J, Park B, Do Y, Jeong SH, Suh C, ... ... Kim HJ, ... ... Kim HR, et al. Front & Back Matter Acta Haematologica. 127. DOI: 10.1159/000337168  1
2011 Yi JH, Huh J, Kim HJ, Kim SH, Kim HJ, Kim YK, Sohn SK, Moon JH, Kim SH, Kim KH, Won JH, Mun YC, Kim H, Park J, Jung CW, et al. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4702-8. PMID 22084373 DOI: 10.1200/JCO.2011.35.5719  0.96
2011 Ahn JS, Yang DH, Jung SH, Bae SY, Tran HT, Park HC, Kim HN, Kim YK, Kim HJ, Lee JJ. Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma. The Korean Journal of Hematology. 46: 180-5. PMID 22065973 DOI: 10.5045/kjh.2011.46.3.180  1
2011 Choi HJ, Kim HR, Shin MG, Kook H, Kim HJ, Shin JH, Suh SP, Ryang DW. Spectra of chromosomal aberrations in 325 leukemia patients and implications for the development of new molecular detection systems. Journal of Korean Medical Science. 26: 886-92. PMID 21738341 DOI: 10.3346/jkms.2011.26.7.886  0.88
2011 Jin XM, Kim HN, Shin MH, Lee IK, Lee JS, Lee JH, Kim HJ, Choi JS, Juhng SW, Choi C. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans. Dna and Cell Biology. 30: 1039-44. PMID 21631283 DOI: 10.1089/dna.2010.1130  1
2011 Kim DH, Lee ST, Won HH, Kim S, Kim MJ, Kim HJ, Kim SH, Kim JW, Kim HJ, Kim YK, Sohn SK, Moon JH, Jung CW, Lipton JH. A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood. 117: 6906-11. PMID 21540461 DOI: 10.1182/blood-2011-01-329797  0.72
2011 Bae SY, Ahn JS, Yang DH, Kim YK, Min JJ, Song HC, Bom HS, Jeong YY, Kim HJ, Lee JJ. A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment. Case Reports in Oncology. 4: 101-5. PMID 21475598 DOI: 10.1159/000324920  1
2011 Yang DH, Kim MH, Lee YK, Hong CY, Lee HJ, Nguyen-Pham TN, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins. Annals of Hematology. 90: 1419-26. PMID 21465188 DOI: 10.1007/S00277-011-1219-Y  1
2011 Sohn SK, Oh SJ, Kim BS, Ryoo HM, Chung JS, Joo YD, Bang SM, Jung CW, Kim DH, Yoon SS, Kim H, Lee HG, Won JH, Min YH, Cheong JW, ... ... Kim H, ... ... Kim HJ, et al. Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia. Leukemia & Lymphoma. 52: 1024-9. PMID 21463107 DOI: 10.3109/10428194.2011.563885  0.96
2011 Lee SJ, Jung CW, Kim DY, Lee KH, Sohn SK, Kwak JY, Kim HJ, Kim IH, Park S, Kim DH. Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia. American Journal of Hematology. 86: 346-50. PMID 21442637 DOI: 10.1002/ajh.21980  0.96
2011 Nguyen-Pham TN, Lim MS, Nguyen TA, Lee YK, Jin CJ, Lee HJ, Hong CY, Ahn JS, Yang DH, Kim YK, Chung IJ, Park BC, Kim HJ, Lee JJ. Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists. Cellular & Molecular Immunology. 8: 341-7. PMID 21423200 DOI: 10.1038/cmi.2011.7  0.96
2011 Yang DH, Min JJ, Song HC, Jeong YY, Chung WK, Bae SY, Ahn JS, Kim YK, Bom HS, Chung IJ, Kim HJ, Lee JJ. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. European Journal of Cancer (Oxford, England : 1990). 47: 1312-8. PMID 21334197 DOI: 10.1016/j.ejca.2010.12.027  1
2011 Koh Y, Kim DY, Park SH, Jung SH, Park E, Kim HJ, Sohn SK, Joo YD, Kim SJ, Shin HJ, Kim SH, Song HS, Chung J, Kim I, Yoon SS, et al. GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization. Cancer Genetics and Cytogenetics. 203: 215-21. PMID 21156236 DOI: 10.1016/j.cancergencyto.2010.08.022  1
2010 Lee HR, Oh B, Hong DS, Zang DY, Yoon HJ, Kim HJ, Kim I, Ahn JS, Cheong JW, Lee KA, Cho KS, Lee MH, Bang SM, Kim TY, Yun YM, et al. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics. 203: 193-202. PMID 21156233 DOI: 10.1016/j.cancergencyto.2010.08.007  0.96
2010 Kim DH, Kong JH, Byeun JY, Jung CW, Xu W, Liu X, Kamel-Reid S, Kim YK, Kim HJ, Lipton JH. The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5339-50. PMID 20959405 DOI: 10.1158/1078-0432.Ccr-10-1638  0.96
2010 Kim HN, Yu L, Kim NY, Lee IK, Kim YK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Kim HJ. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma. American Journal of Hematology. 85: 822-4. PMID 20734458 DOI: 10.1002/ajh.21834  1
2010 Ryu J, Lee SR, Park SG, Kang S, Kim HJ, Park BC. Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin. Experimental & Molecular Medicine. 42: 651-61. PMID 20716902 DOI: 10.3858/Emm.2010.42.9.065  0.96
2010 Kim HJ, Jin XM, Kim HN, Lee IK, Park KS, Park MR, Jo DY, Won JH, Kwak JY, Kim HJ, Choi JS, Juhng SW, Choi C. Fas and FasL polymorphisms are not associated with acute myeloid leukemia risk in Koreans. Dna and Cell Biology. 29: 619-24. PMID 20438363 DOI: 10.1089/dna.2010.1032  0.96
2010 Pham TN, Hong CY, Min JJ, Rhee JH, Nguyen TA, Park BC, Yang DH, Park YK, Kim HR, Chung IJ, Kim HJ, Lee JJ. Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist. Experimental & Molecular Medicine. 42: 407-19. PMID 20386085 DOI: 10.3858/emm.2010.42.6.042  0.56
2010 Park JE, Park BC, Kim HA, Song M, Park SG, Lee do H, Kim HJ, Choi HK, Kim JT, Cho S. Positive regulation of apoptosis signal-regulating kinase 1 by dual-specificity phosphatase 13A. Cellular and Molecular Life Sciences : Cmls. 67: 2619-29. PMID 20358250 DOI: 10.1007/s00018-010-0353-3  0.96
2010 Yang DH, Kim MH, Hong CY, Lee YK, Jin CJ, Pham TN, Ahn JS, Bae WK, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Annals of Hematology. 89: 795-801. PMID 20238114 DOI: 10.1007/S00277-010-0931-3  1
2010 Shin HJ, Kim HJ, Sohn SK, Min YH, Won JH, Kim I, Yoon HJ, Lee JH, Jo DY, Joo YD, Jung CW, Lee KH, Chung JS, Ahn JS, et al. Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment. Japanese Journal of Clinical Oncology. 40: 556-66. PMID 20185460 DOI: 10.1093/jjco/hyq007  1
2010 Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Joo YD, Won JH, Park MR, et al. Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors. Annals of Hematology. 89: 813-20. PMID 20177897 DOI: 10.1007/s00277-010-0913-5  0.96
2010 Kang SJ, Park KH, Jung SI, Jang HC, Ji SY, Ahn JS, Kim HJ, Shin JH, Kim DM. Scrub typhus induced by peripheral blood stem cell transplantation in the immunocompromised patient: diagnostic usefulness of nested polymerase chain reaction. Transfusion. 50: 467-70. PMID 19843286 DOI: 10.1111/j.1537-2995.2009.02442.x  0.96
2010 Kim DY, Lee JH, Lee JH, Lee KH, Kim YK, Ahn JS, Kim HJ, Kim I, Yoon SS, Park S, Bae SH, Bang SM, Lee HG, Shin HJ, Lee JH, et al. Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine. Annals of Hematology. 89: 15-23. PMID 19543727 DOI: 10.1007/s00277-009-0771-1  1
2009 Choi HJ, Shin MG, Kim HR, Kim HJ, Kook H, Kee SJ, Kim SH, Shin JH, Suh SP, Ryang DW. [Detection of putative T cell clones using T cell receptor beta chain gene clonality assay in Korean patients with aplastic anemia]. The Korean Journal of Laboratory Medicine. 29: 269-76. PMID 19726886 DOI: 10.3343/kjlm.2009.29.4.269  0.88
2009 Lee SR, Yang DH, Ahn JS, Kim YK, Lee JJ, Choi YJ, Shin HJ, Chung JS, Cho YY, Chae YS, Kim JG, Sohn SK, Kim HJ. The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia. Journal of Korean Medical Science. 24: 498-503. PMID 19543516 DOI: 10.3346/jkms.2009.24.3.498  1
2009 Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, et al. Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3472-9. PMID 19487385 DOI: 10.1200/JCO.2007.14.3339  0.96
2009 Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ, Lee JJ, Chung IJ, Juhng SW, Kim HJ. Polymyositis and myocarditis after donor lymphocyte infusion. International Journal of Hematology. 90: 113-116. PMID 19472035 DOI: 10.1007/s12185-009-0332-3  0.44
2009 Ju HS, Seung HK, Cho D, Lee IK, Kim HJ, Tae SK. Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2 International Journal of Cancer. 125: 1074-1081. PMID 19449375 DOI: 10.1002/ijc.24386  0.96
2009 Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Cho SH, Lee JJ, Kim HJ, Chung IJ. Metastatic breast cancer presenting as cancer of unknown primary associated with superior vena cava syndrome. The Breast Journal. 15: 202-3. PMID 19292809 DOI: 10.1111/j.1524-4741.2009.00698.x  0.44
2009 Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim HJ, Kim TS. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. International Journal of Oncology. 34: 1165-71. PMID 19287976 DOI: 10.3892/ijo_00000245  0.92
2009 Kim SK, Nguyen Pham TN, Nguyen Hoang TM, Kang HK, Jin CJ, Nam JH, Chung SY, Choi SJ, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens. Annals of Hematology. 88: 1113-23. PMID 19277657 DOI: 10.1007/s00277-009-0721-y  0.56
2009 Park YH, Sohn SK, Kim JG, Lee MH, Song HS, Kim MK, Jung JS, Lee JJ, Kim HJ, Kim DH. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2107-15. PMID 19276283 DOI: 10.1158/1078-0432.CCR-08-1588  0.6
2009 Kim DH, Kamel-Reid S, Chang H, Sutherland R, Jung CW, Kim HJ, Lee JJ, Lipton JH. Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia. Haematologica. 94: 135-9. PMID 19066329 DOI: 10.3324/Haematol.13151  1
2009 Yang DH, Park JS, Jin CJ, Kang HK, Nam JH, Rhee JH, Kim YK, Chung SY, Choi SJ, Kim HJ, Chung IJ, Lee JJ. The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma. Leukemia Research. 33: 665-70. PMID 18922577 DOI: 10.1016/j.leukres.2008.09.006  0.96
2009 Kim HN, Kim YK, Lee IK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Park MR, Jo DY, Won JH, Kwak JY, Kim HJ. Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leukemia Research. 33: 82-7. PMID 18774170 DOI: 10.1016/j.leukres.2008.07.026  1
2009 Ha Kim K, Kim DHD, Jang JH, Kim K, Jung CW, Won J, Moon JH, Sohn SK, Kim Y, Yang D, Lee J, Kim H, Kim JS, Min YH, Kim D, et al. Multicenter Retrospective Analysis of Second Allogeneic HSCT Outcomes for Hematologic Malignancies in Korea. Blood. 114: 4298-4298. DOI: 10.1182/blood.v114.22.4298.4298  0.96
2009 Lee HR, Hong DS, Zang DY, Lee HG, Yoon H, Kim H, Kim I, Ahn J, Lee J, Cheong J, Lee K, Bang S, Park SY, Yun YM, Min Y, et al. Incidence and Biologic Features of 5q Deletion and 5q- Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008. Blood. 114: 2778-2778. DOI: 10.1182/Blood.V114.22.2778.2778  0.92
2008 Kim HR, Shin MG, Kim MJ, Kim HJ, Shin JH, Suh SP, Ryang DW. Mitochondrial DNA aberrations of bone marrow cells from patients with aplastic anemia. Journal of Korean Medical Science. 23: 1062-7. PMID 19119453 DOI: 10.3346/jkms.2008.23.6.1062  0.88
2008 Yang DH, Min JJ, Jeong YY, Ahn JS, Kim YK, Cho SH, Chung IJ, Bom HS, Kim HJ, Lee JJ. The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. Annals of Hematology. 88: 425-32. PMID 19002686 DOI: 10.1007/s00277-008-0616-3  0.4
2008 Hwang J, Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ. Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. Journal of Korean Medical Science. 23: 586-91. PMID 18756042 DOI: 10.3346/jkms.2008.23.4.586  0.36
2008 Hwang JE, Cho SH, Kim OK, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ. Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone. Journal of Korean Medical Science. 23: 544-7. PMID 18583898 DOI: 10.3346/jkms.2008.23.3.544  0.68
2008 Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, Yang DH, Kim HJ, Kim JG, Joo YD, Lee WS, Sohn CH, Lee EY, Cho GJ. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. Journal of Korean Medical Science. 23: 439-44. PMID 18583880 DOI: 10.3346/jkms.2008.23.3.439  0.48
2008 Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Yang DH, Lee JJ, Kim YK, Kim HJ, Shin HJ, Chung JS, Cho GJ. Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors. American Journal of Hematology. 83: 649-53. PMID 18528826 DOI: 10.1002/ajh.21215  1
2008 Lee JJ, Choi BH, Kang HK, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients. Leukemia Research. 32: 1653-60. PMID 18501426 DOI: 10.1016/j.leukres.2008.03.038  1
2008 Lee JH, Min YH, Chung CW, Kim BK, Yoon HJ, Jo DY, Shin HJ, Bang SM, Won JH, Zang DY, Kim HJ, Chi HS, Lee KH, Cheong JW, Kim JS, et al. Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leukemia & Lymphoma. 49: 700-9. PMID 18398737 DOI: 10.1080/10428190701843247  1
2008 Kim YK, Shin MG, Kim HR, Yang DH, Cho SH, Lee JJ, Chung IJ, Ryang DW, Kim HJ. Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders Leukemia Research. 32: 993-995. PMID 18055011 DOI: 10.1016/j.leukres.2007.10.018  0.88
2008 Kim JY, Song HJ, Lim HJ, Shin MG, Kim JS, Kim HJ, Kim BY, Lee SW. Platelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission. Molecular & Cellular Proteomics : McP. 7: 431-41. PMID 17998245 DOI: 10.1074/mcp.M700194-MCP200  0.96
2008 Ahn JS, Yang DH, Kim YK, Cho SH, Kim IY, Lee JJ, Chung IJ, Kim HJ. Multiple intracranial tuberculomas mimicking granulocytic sarcomas in acute myeloid leukemia. Journal of Korean Medical Science. S171-3. PMID 17923749 DOI: 10.3346/jkms.2007.22.S.S171  0.36
2008 Koh JM, Oh B, Lee JY, Lee JK, Kimm K, Park BL, Shin HD, Lee IK, Kim HJ, Hong JM, Kim TH, Kim GS, Kim SY, Park EK. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 22: 1752-8. PMID 17620055 DOI: 10.1359/JBMR.070705  0.52
2008 Koh Y, Kim D, Kwon H, Kim MK, Kim B, Kim Y, Kim I, Kim JS, Kim JS, Kim CS, Kim H, Kwak J, Lee N, Min Y, Park CW, et al. Molecular Predictive Markers in Dose Escalation Treatment for Suboptimal Responders to Standard Dose Imatinib in CML Blood. 112: 3221-3221. DOI: 10.1182/blood.v112.11.3221.3221  0.96
2007 Nguyen Pham TN, Choi BH, Kang HK, Jin CC, Minh NH, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ, Lee JJ. Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 39: 175-80. PMID 19746185 DOI: 10.4143/crt.2007.39.4.175  1
2007 Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, Shin MH, Park KS, Shin MG, Choi JS, Kim HJ. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. British Journal of Haematology. 140: 287-94. PMID 18042267 DOI: 10.1111/J.1365-2141.2007.06893.X  0.36
2007 Kim HI, Chung SH, Hwang JE, Kim SH, Ahn JS, Yang DH, Kim YK, Yun SJ, Cho SH, Lee JJ, Chung IJ, Kim HJ. Dermatomyositis associated with cancer of unknown primary site. Journal of Korean Medical Science. 22: S174-7. PMID 17923750 DOI: 10.3346/jkms.2007.22.S.S174  1
2007 Lee JJ, Choi BH, Kang HK, Park MS, Park JS, Kim SK, Pham TN, Cho D, Nam JH, Kim YJ, Rhee JH, Yang DH, Kim YK, Kim HJ, Chung IJ. Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates. Leukemia & Lymphoma. 48: 2022-31. PMID 17917970 DOI: 10.1080/10428190701583975  0.96
2007 Shin MG, Lee JS, Cho D, Kim SH, Shin JH, Suh SP, Ryang DW, Sawyer JR, Kim HR, Yang DH, Kim HJ. Adult T-cell leukemia/lymphoma with a complex karyotype and central nervous system involvement Cancer Genetics and Cytogenetics. 177: 78-80. PMID 17693198 DOI: 10.1016/j.cancergencyto.2007.05.006  0.88
2007 Kim HN, Kim YK, Lee IK, Lee JJ, Yang DH, Park KS, Choi JS, Park MR, Jo DY, Kim HJ. Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma. American Journal of Hematology. 82: 798-801. PMID 17546637 DOI: 10.1002/ajh.20967  0.52
2007 Lee JJ, Kim DH, Lee NY, Sohn SK, Kim JG, Kim HJ, Do YR, Park YH. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. British Journal of Haematology. 137: 329-36. PMID 17408400 DOI: 10.1111/j.1365-2141.2007.06570.x  0.6
2007 Kim JG, Sohn SK, Chae YS, Cho YY, Yang DH, Lee JJ, Kim HJ, Shin HJ, Chung JS, Cho GJ, Lee WS, Joo YD, Sohn CH, Oh SJ. Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study. Cancer Chemotherapy and Pharmacology. 60: 129-34. PMID 17406867 DOI: 10.1007/s00280-007-0469-9  1
2007 Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH, Chung IJ, Seong CM, Kim HJ. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation. American Journal of Hematology. 82: 1-5. PMID 16986129 DOI: 10.1002/ajh.20739  1
2006 Choi HW, Shin MG, Kim HJ, Lee IK, Yun JH, Kim HR, Kim YK, Yun HK, Cho D, Kee SJ, Shin JH, Suh SP, Ryang DW. [Biphenotypic Acute Leukemia with BCR-ABL mRNA Transcript b3a2 Type: A Case Report with Review of the Literature.]. The Korean Journal of Laboratory Medicine. 26: 249-54. PMID 18156734 DOI: 10.3343/kjlm.2006.26.4.249  0.96
2006 Baek JH, Sohn SK, Kim DH, Kim JG, Yang DH, Kim YK, Lee JJ, Kim HJ. Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemia. Acta Haematologica. 117: 109-14. PMID 17135724 DOI: 10.1159/000097386  0.56
2006 Choi BH, Kang HK, Park JS, Kim SK, Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. Journal of Clinical Apheresis. 21: 233-40. PMID 17120232 DOI: 10.1002/jca.20105  0.96
2006 Kang HK, Park JS, Kim SK, Choi BH, Pham TN, Zhu XW, Cho D, Nam JH, Kim YJ, Rhee JH, Chung IJ, Kim HJ, Lee JJ. Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia. Leukemia & Lymphoma. 47: 2224-33. PMID 17071499 DOI: 10.1080/10428190600732236  0.96
2006 Choi HW, Shin MG, Sawyer JR, Cho D, Kee SJ, Baek HJ, Kook H, Kim HJ, Shin JH, Suh SP, Hwang TJ, Ryang DW. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47,XX,+10,t(16;21)(p11;q22). Cancer Genetics and Cytogenetics. 167: 172-6. PMID 16737920 DOI: 10.1016/j.cancergencyto.2006.01.003  0.96
2006 Kim SH, Song JH, Choi BG, Kim HJ, Kim TS. Chemical modification of santonin into a diacetoxy acetal form confers the ability to induce differentiation of human promyelocytic leukemia cells via the down-regulation of NF-kappaB DNA binding activity. The Journal of Biological Chemistry. 281: 13117-25. PMID 16554308 DOI: 10.1074/jbc.M510944200  0.32
2006 Shin MG, Levin BC, Kim HJ, Kim HR, Lee IK, Cho D, Kee SJ, Shin JH, Suh SP, Ryang DW. Profiling of length heteroplasmies in the human mitochondrial DNA control regions from blood cells in the Korean population. Electrophoresis. 27: 1331-40. PMID 16502464 DOI: 10.1002/elps.200500551  0.88
2006 Bang SM, Kim YK, Park YH, Sohn SK, Lee JJ, Cho EK, Ryoo BY, Chung IJ, Yoon SS, Kim HJ, Lee JH, Yoon HJ, Park S. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Leukemia & Lymphoma. 46: 1599-1604. PMID 16334486 DOI: 10.1080/10428190500215191  0.56
2006 Kim JG, Sohn SK, Chae YS, Kim DH, Baek JH, Lee KB, Lee JJ, Chung IJ, Kim HJ, Yang DH, Lee WS, Joo YD, Sohn CH. CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology. 58: 35-9. PMID 16308699 DOI: 10.1007/s00280-005-0136-y  1
2005 Cho SH, Chung IJ, Song SY, Yang DH, Byun JR, Kim YK, Lee JJ, Na KJ, Kim HJ. Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer. Journal of Korean Medical Science. 20: 618-23. PMID 16100454 DOI: 10.3346/jkms.2005.20.4.618  0.6
2005 Dong HK, Sang KS, Jin HB, Jong GK, Jong WL, Woo SM, Dong WK, Choi SJ, Lee JH, Lee KH, Mark HL, Je JL, Hyeoung JK, Chun CK, Kyu BL. Retrospective multicenter study of allogeneic peripheral blood stem cell transplantation followed by reduced-intensity conditioning or conventional myeloablative regimen Acta Haematologica. 113: 220-227. PMID 15983427 DOI: 10.1159/000084674  0.48
2005 Lee JJ, Choi BH, Nam JH, Park MS, Song WH, Yang DH, Kim YK, Cho SH, Chung IJ, Park KS, Lee IK, Kim HJ. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage. Journal of Clinical Apheresis. 19: 130-6. PMID 15493054 DOI: 10.1002/jca.20015  0.48
2005 Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, Park KS, Lee IK, Chung IJ, Hwang TJ, Kim HJ. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. Journal of Clinical Apheresis. 19: 66-70. PMID 15274198 DOI: 10.1002/jca.10080  0.36
2004 Lee JJ, Kim YK, Cho SH, Park KS, Chung IJ, Cho D, Ryang DW, Kim HJ. Hemolytic Anemia as a Sequela of Arsenic Intoxication Following Long-Term Ingestion of Traditional Chinese Medicine Journal of Korean Medical Science. 19: 127-129. PMID 14966354 DOI: 10.3346/jkms.2004.19.1.127  0.96
2003 Song JH, Kim JM, Kim SH, Kim HJ, Lee JJ, Sung MH, Hwang SY, Kim TS. Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sciences. 73: 1705-19. PMID 12875902 DOI: 10.1016/S0024-3205(03)00515-0  1
2003 Lee JJ, Cho D, Chung IJ, Cho SH, Park KS, Park MR, Ryang DW, Kim HJ. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia American Journal of Hematology. 73: 149-153. PMID 12827650 DOI: 10.1002/ajh.10337  0.96
2002 Lee JJ, Chung IJ, Yang DH, Cho SH, Cho D, Ryang DW, Kim HJ. Clinical significance of CD56 expression in patients with acute myeloid leukemia [4] Leukemia and Lymphoma. 43: 1897-1899. PMID 12685854 DOI: 10.1080/1042819021000009283  0.96
2002 Kim SH, Kang SN, Kim HJ, Kim TS. Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone. Biochemical Pharmacology. 64: 1233-42. PMID 12234604 DOI: 10.1016/S0006-2952(02)01292-3  0.52
2002 Cho JG, Ahn YK, Cho SH, Lee JJ, Chung IJ, Park MR, Kim HJ, Jeong MH, Park JC, Kang JC. A case of secondary myocardial lymphoma presenting with ventricular tachycardia Journal of Korean Medical Science. 17: 549-551. PMID 12172054 DOI: 10.3346/jkms.2002.17.4.549  0.96
2002 Chung IJ, Lee JJ, Park MR, Kook H, Cho SH, Hwang TJ, Kim HJ. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia. Journal of Korean Medical Science. 17: 468-74. PMID 12172040 DOI: 10.3346/jkms.2002.17.4.468  1
2002 Lee JJ, Chung IJ, Shin DH, Cho SH, Cho D, Ryang DW, Khan AS, Kim HJ. Hemorrhagic fever with renal syndrome presenting with hemophagocytic lymphohistiocytosis Emerging Infectious Diseases. 8: 209-210. PMID 11897077 DOI: 10.3201/eid0802.010299  0.96
2001 Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS, Sohn SK, Kim JS, Shin DG, Ryoo HM, Lee KH, Lee JJ, Chung IJ, Kim HJ, Kwak JY, et al. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. American Journal of Hematology. 66: 197-202. PMID 11279626 DOI: 10.1002/1096-8652(200103)66:3<197::AID-AJH1044>3.0.CO;2-6  0.44
2000 Lee JJ, Chung IJ, Park MR, Yang DH, Cho SH, Ryang DW, Kim HJ. Acquired hemophilia successfully treated with oral immunosuppressive therapy Korean Journal of Internal Medicine. 15: 135-137. PMID 10992727 DOI: 10.3904/KJIM.2000.15.2.135  0.76
1998 Kim HJ, Chung IJ, Lee JJ, Seo JS, Park MR, Choi KS, Kook H, Hwang TJ. A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation. The Korean Journal of Internal Medicine. 13: 60-3. PMID 9538634 DOI: 10.3904/kjim.1998.13.1.60  0.52
1996 Kim YC, Park KO, Choi IS, Kim HJ, Lim SC, Bom HS. A comparison of serum CYFRA 21-1 and SCC Ag in the diagnosis of squamous cell lung carcinoma. The Korean Journal of Internal Medicine. 11: 50-7. PMID 8882476 DOI: 10.3904/kjim.1996.11.1.50  0.44
1996 Kim YC, Park KO, Kim HJ, Choi IS, Park CS, Juhng SW. DNA ploidy and proliferative activity in bcl-2 expressed non-small cell lung cancer. The Korean Journal of Internal Medicine. 11: 101-7. PMID 8854645 DOI: 10.3904/kjim.1996.11.2.101  0.48
Show low-probability matches.